KRTL BioTech

Latest News on private equity markets

Oil prices nudge up on Chinese economic data

Oil prices rose slightly on Monday as Chinese industrial output and retail data topped expectations but gains were capped by overall figures showing the country's slowest quarterly economic growth in decades.



6 years ago

Hold the beers: Budweiser APAC IPO hit by investor push-back

Scepticism over AB InBev's high valuations doomed Budweiser APAC's IPO of up to $9.8 billion - poised to be the world's biggest this year - investors and bankers said, putting would-be floats on notice that careful pricing remains key to success.



6 years ago

Reassuring Chinese data nudges shares higher

Surprisingly upbeat economic soundings from China lifted the global markets mood on Monday, pushing world shares toward an 18-month high and steering the Aussie dollar and copper upwards.



6 years ago

Gilead invests $5 bln to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares 18 percent to an all-time high on Monday.



6 years ago

Oklahoma, J&J to wrap up first trial over opioid crisis

Oklahoma's attorney general is expected on Monday to urge a judge to find Johnson & Johnson responsible for flooding the market with painkillers and fueling the U.S. opioid epidemic, as the first trial in nationwide litigation over the drug crisis comes to an end.



6 years ago

Oil prices edge higher on Chinese economic data

Oil prices rose slightly on Monday as Chinese industrial output and retail data topped expectations but gains were capped by overall figures showing the country's slowest quarterly economic growth in decades.



6 years ago

Trump sees slowing Chinese growth pressuring Beijing on trade

U.S. President Donald Trump on Monday pointed to slowing economic growth in China amid restarted trade talks, saying U.S. tariffs were having "a major effect" and warning that "possibly much more" were to come.



6 years ago

UBS downgrades GE after 42% run-up this year: 'Taking a breather'

UBS lowered its rating on shares of General Electric to neutral from buy on Monday.

6 years ago

Stock futures slightly higher ahead of Citi results

U.S. stock futures extended last week's gains to trade slightly higher on Monday in the run up to the start of second-quarter earnings reports, beginning with Citigroup.



6 years ago

Ford, UAW to kick off contentious contract talks

The United Auto Workers and Ford Motor Co will officially launch talks on a four-year contract on Monday that are expected to be contentious, with rising healthcare costs, job security and the use of temporary workers expected to be major sticking points.



6 years ago

Retailers cash in on Amazon's 'free marketing' on Prime Day

Amazon.com Inc's Prime Day is now a major marketing opportunity and shopping event in the annual calendar for other U.S. retail companies, rivaling the Thanksgiving holiday's Black Friday as a driver of sales.



6 years ago

Huawei to invest $3.1 billion in Italy, add 1,000 jobs in three years: country CEO

China's Huawei Technologies will invest $3.1 billion in Italy over the next three years, the chief executive of the telecoms giant's Italian unit, Thomas Miao, said on Monday.



6 years ago

Wall Street set open higher as banks rise after Citi results

Wall Street was set to extend last week's gains at the open on Monday as second-quarter corporate earnings got off to an upbeat start with results from the third largest U.S lender, Citigroup, beating expectations.



6 years ago

Gilead invests $5 billion to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares 18 percent to an all-time high on Monday.



6 years ago

Factbox: The Galapagos drugs pipeline that has drawn in Gilead

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV .



6 years ago